搜索结果

Search Results for " influenza a h1n1 (a/brisbane/02/2018) neuraminidase/na protein (his) "

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

* 搜索：		* 机关/企业：
* 邮箱：		* 电话：
备注：
验证码：

Cat. No.	Product Name	Species	Expression System
TMPY-06067	Influenza A H1N1 (A/Brisbane/02/2018) Neuraminidase/NA Protein (His) NA Protein	H1N1	Baculovirus Insect Cells
	Influenza A H1N1 (A/Brisbane/02/2018) Neuraminidase/NA Protein (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 54.3 kDa.
TMPK-01422	Peptide Ready HLA-A02:01&B2M Monomer Protein, Human, MHC (His* & Avi) Peptide Ready,MHC,HLA-	Human	HEK293 Cells
	Peptide Ready HLA-A02:01&B2M Monomer is absent from peptide, namely peptide-receptive MHC. It can be loaded with antigenic peptides matching HLA-A02:01. Peptide ready MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner.
TMPK-01410	Peptide Ready HLA-A24:02&B2M Monomer Protein, Human, MHC (His* & Avi) HLA-A,MHC,Peptide Re...	Human	HEK293 Cells
	Peptide Ready HLA-G&B2M Monomer is absent from peptide, namely peptide-receptive MHC. It can be loaded with antigenic peptides matching HLA-G. Peptide ready MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner.
TMPK-01421	Peptide Ready HLA-A02:01&B2M Monomer Protein, Human, MHC (His* & Avi), Biotinylated HLA-A*02:01,MHC...	Human	HEK293 Cells
	HLA-A02:01&B2M&Peptide ready Monomer is absent from peptide, namely peptide-receptive MHC. It can be loaded with antigenic peptides matching HLA-A02:01. Peptide ready MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner.
TMPK-01409	Peptide Ready HLA-A24:02&B2M Monomer Protein, Human, MHC (His* & Avi), Biotinylated Peptide Ready,MHC,HLA-	Human	HEK293 Cells
	Peptide Ready HLA-G&B2M Monomer is absent from peptide, namely peptide-receptive MHC. It can be loaded with antigenic peptides matching HLA-G. Peptide ready MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner.
TMPK-01415	APC-equivalent Peptide Ready HLA-A02:01&B2M Tetramer Protein, Human, MHC (His*) Peptide Ready,HLA-	Human	HEK293 Cells
	Peptide Ready HLA-A02:01&B2M Tetramer is absent from peptide, namely peptide-receptive MHC. It can be loaded with antigenic peptides matching HLA-A02:01. Peptide ready MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner.
TMPK-01408	HLA-A02:01&B2M&KRAS G12V (KLVVVGAVGV) Monomer Protein, Human, MHC (His* & Avi), Biotinylated RALD,KRAS1,KRA	Human	E. coli
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
TMPK-01449	HLA-A02:01&B2M&NY-ESO-1 (SLLMWITQC) Monomer Protein, Human, MHC (E. coli, His* & Avi) MHC,CT6.1,CTAG1,LAGE-2,M...	Human	E. coli
	NY-ESO-1 or New York esophageal squamous cell carcinoma 1 is a well-known cancer-testis antigen (CTAs) with re-expression in numerous cancer types. Its ability to elicit spontaneous humoral and cellular immune responses, together with its restricted expression pattern, have rendered it a good candidate target for cancer immunotherapy.
TMPK-01455	HLA-A02:01&B2M&PRAME (SLLQHLIGL) Monomer Protein, Human, MHC (His* & Avi) OIP4,PRAME,OIP-4,MAPE	Human	HEK293 Cells
	PRAME (PReferentially expressed Antigen in MElanoma) is a melanoma-associated antigen expressed in cutaneous and ocular melanomas and some other malignant neoplasms, while its expression in normal tissue and benign tumors is limited.
TMPK-01473	HLA-A24:02&B2M&MAGE-A3 (IMPKAGLLI) Monomer Protein, Human, MHC (His* & Avi), Biotinylated CT1.3,MAGE-3,MZ2-D,MZ2D,HLA	Human	HEK293 Cells
	Melanoma antigen gene A3 (MAGE-A3) is one of the most immunogenic cancer testis antigens and is common in various types of cancers. MAGE-A3 can be considered as a predictor for poor prognosis and an option for vaccine immunotherapy in patients with PCa.
TMPK-01445	HLA-A02:01&B2M&MAGE-A1 (KVLEYVIKV) Monomer Protein, Human, MHC (His* & Avi), Biotinylated CT1.1,MAGE1,MAGE-1,M...	Human	HEK293 Cells
	MAGE-A1 belongs to the chromosome X-clustered genes of cancer-testis antigen family and is normally expressed in the human germ line but is also overexpressed in various tumors.
TMPK-01477	HLA-A02:01&B2M&AFP (FMNKFIYEI) Monomer Protein, Human, MHC (His* & Avi), Biotinylated HPAFP,FETA,A	Human	HEK293 Cells
	Alpha-fetoprotein (AFP), a specific liver cancer marker, T cells expressing AFP-CAR selectively degranulated, released cytokines, and lysed liver cancer cells that were HLA-A02:01 /AFP while sparing cells from multiple tissue types that were negative for either expressed protein*s.CAR T-cell immunotherapy targeting intracellular/secreted solid tumor antigens can elicit a potent antitumor response.
TMPK-01442	HLA-A02:01&B2M&P53 WT (HMTEVVRRC) Tetramer Protein, Human, MHC (His* & Avi), PE-Labeled HLA-A,P53,TP53,LFS1,MHC,...	Human	HEK293 Cells
	p53 is a tumor suppressor protein. Under stressful conditions, p53 tightly regulates cell growth by promoting apoptosis and DNA repair. When p53 becomes mutated, it loses its function, resulting in abnormal cell proliferation and tumor progression. Depending on the p53 mutation, it has been shown to form aggregates leading to negative gain of function of the protein. p53 mutant associated aggregation has been observed in several cancer tissues and has been shown to promote tumor growth.
TMPK-01480	HLA-A02:01&B2M&Survivin (LMLGEFLKL) Monomer Protein, Human, MHC (His* & Avi), Biotinylated IAP4,Survivin,API4,BIRC5...	Human	HEK293 Cells
	Survivin (also known as BIRC5) is an evolutionarily conserved eukaryotic protein that is essential for cell division and can inhibit cell death. Normally it is only expressed in actively proliferating cells, but is upregulated in most, if not all cancers; consequently, it has received significant attention as a potential oncotherapeutic target.
TMPK-01500	HLA-A02:01&B2M&NY-ESO-1 (SLLMWITQV) Monomer Protein, Human, MHC (His* & Avi) CTAG1,CT6.1,CTAG1B,L...	Human	HEK293 Cells
	NY-ESO-1 or New York esophageal squamous cell carcinoma 1 is a well-known cancer-testis antigen (CTAs) with re-expression in numerous cancer types. Its ability to elicit spontaneous humoral and cellular immune responses, together with its restricted expression pattern, have rendered it a good candidate target for cancer immunotherapy.
TMPK-01539	HLA-A02:01&B2M&NY-ESO-1 (SLLMWITQC) Monomer Protein, Human, MHC (His* & Avi), Biotinylated CTAG1B,CT6.1,MY-ESO-1,LA...	Human	HEK293 Cells
	NY-ESO-1 or New York esophageal squamous cell carcinoma 1 is a well-known cancer-testis antigen (CTAs) with re-expression in numerous cancer types. Its ability to elicit spontaneous humoral and cellular immune responses, together with its restricted expression pattern, have rendered it a good candidate target for cancer immunotherapy.
TMPK-01484	HLA-A02:03&B2M&AFP (FMNKFIYEI) Monomer Protein, Human, MHC (His* & Avi) HPAFP,FETA,A	Human	HEK293 Cells
	Alpha-fetoprotein (AFP), a specific liver cancer marker, T cells expressing AFP-CAR selectively degranulated, released cytokines, and lysed liver cancer cells that were HLA-A02:01 /AFP while sparing cells from multiple tissue types that were negative for either expressed protein*s.CAR T-cell immunotherapy targeting intracellular/secreted solid tumor antigens can elicit a potent antitumor response.
TMPK-01448	HLA-A02:01&B2M&NY-ESO-1 (SLLMWITQC) Tetramer Protein, Human, MHC (E. coli, His* & Avi) MHC,LAGE-2,NY-ESO-1,ESO1CTA	Human	E. coli
	NY-ESO-1 or New York esophageal squamous cell carcinoma 1 is a well-known cancer-testis antigen (CTAs) with re-expression in numerous cancer types. Its ability to elicit spontaneous humoral and cellular immune responses, together with its restricted expression pattern, have rendered it a good candidate target for cancer immunotherapy.
TMPK-01467	HLA-A02:01&B2M&HPV 16 E6 (KLPQLCTEL) Monomer Protein, Human, MHC (His* & Avi) HPV16,E6,Human papillom<...	Human	HEK293 Cells
	Human papillomavirus (HPV) 16 infection is a necessary condition for the pathogenesis and development of cervical cancer. The E6 protein is expressed by the HPV16 E6 gene and promotes malignant phenotype transformation, which is an important mechanism for the occurrence and development of cervical cancer.
TMPK-01520	HLA-A02:01&B2M&AFP (PLFQVPEPV) Tetramer Protein, Human, MHC (His* & Avi) Alpha-1-fetoprotein<...	Human	HEK293 Cells
	Alpha-fetoprotein (AFP), a specific liver cancer marker, T cells expressing AFP-CAR selectively degranulated, released cytokines, and lysed liver cancer cells that were HLA-A02:01 /AFP while sparing cells from multiple tissue types that were negative for either expressed protein*s.CAR T-cell immunotherapy targeting intracellular/secreted solid tumor antigens can elicit a potent antitumor response.

搜索结果

提交您的定制咨询

重组蛋白